William Blair analyst Raju Prasad reiterated an Outperform rating on Alexion Pharmaceuticals (NASDAQ: ALXN) but views the company as an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE